LATE-BREAKING ABSTRACTS

The Canadian Stroke Congress welcomes the submission of late-breaking scientific abstracts for recently completed clinical trials and or large observational studies that feature recent high-impact scientific discoveries where data was not available for submission during the main call for abstracts.

Most late-breaking trials will be offered a poster presentation or brief oral communications. Up to two abstracts may be selected for an oral presentation if results have significant impact on stroke care delivery.

Abstracts submitted during this time that do not meet the criteria of a late-breaking abstract will not be reviewed or considered for inclusion.

Deadline for abstracts is Friday, June 28

Abstract submission guidelines

  • Abstract are welcome from national and international applicants from all disciplines across the continuum of care, including healthcare providers, researchers, system leaders, and people with lived experience.
  • Authors may submit multiple abstracts as first author or co-author
  • Abstracts may be submitted in English or French and presentations at Congress may be given in either language.
  • Each abstract should be a maximum of 250 words (excluding title and authors) and should consist of four separate paragraphs when appropriate:

    • Background : briefly describe the problem or issue being addressed
    • Methods: describe how the study was performed
    • Results: outline key findings
    • Conclusions: describe what the authors conclude from these results

  • ONE table or graph upload is allowed per abstract. File size is limited to 5mb and JPEG only. Uploads can be made on the specified upload page in submission

  • Applicants must select one of the following categories at submission where their abstract fits best

    • Acute stroke management
    • Prevention of stroke (primary and secondary)
    • Stroke rehabilitation, recovery, and community care
    • Stroke systems of care.
    • Engagement of people with lived experience with stroke

  • All abstracts will be peer-reviewed.

    • Highly ranked late-breaking abstracts may be featured either as oral presentations (eight minutes + two minutes for questions), or traditional paper display posters.

  • Learning objectives (at least one and up to three) must be submitted with abstract.
  • Research presented in abstracts must conform to CIHR guidelines for experimental procedures. All investigations involving humans and animals must have been conducted in conformity with these principles.
  • Authors must confirm that all presented works are original works or works that have been properly cited, and/or have obtained appropriate permissions to include.

  • Information for presenters following acceptance of an abstract:

    • Notifications of acceptance will be e-mailed by August 9, 20.19
    • All presenters must register for the Congress and will be required to pay the appropriate registration fee. Abstract presenters do not receive complimentary registration.
    • All accepted presenters are required to complete a Conflict-of-Interest declaration form. Authors must declare any financial interest in a product discussed in the presentation. In general, generic names should always be used rather than specific trade names
    • Display posters will be available for viewing to all delegates throughout the Congress. Poster presenters will be asked to be available at their poster to answer questions at set times during Congress.
    • The accepted abstracts will be published in the International Journal of Stroke Online, in early October, 2019.